Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers

US9364454B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9364454-B2
Application numberUS-201213625865-A
CountryUS
Kind codeB2
Filing dateSep 24, 2012
Priority dateOct 3, 2005
Publication dateJun 14, 2016
Grant dateJun 14, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention describes novel isolated, purified, 10,17-dihydroxy-docosahexaenoic acids, esters, derivatives and their preparation.

First claim

Opening claim text (preview).

We claim: 1. A purified compound of formula (I), (III), (IV), (V), or (VIII): wherein R is a hydrogen atom, an alkyl group, or a pharmaceutically acceptable salt; P 1 and P 2 are each, individually, a hydrogen atom or a protecting group and * indicates bonds are, independently, in the R or S configuration. 2. The compound of claim 1 , wherein when P 1 and P 2 are both hydrogen atoms, then R is other than a hydrogen atom. 3. The compound of claim 1 , wherein P 1 and P 2 are each hydrogen atoms and R is a hydrogen atom. 4. A composition comprising a compound of claim 1 , and a pharmaceutically acceptable carrier. 5. A method to treat airway inflammation comprising administration of a therapeutically acceptable amount of a compound of claim 1 . 6. The method of claim 5 , wherein P 1 and P 2 are each hydrogen atoms and R is a hydrogen atom. 7. The method of claim 5 , wherein said airway inflammation is asthma. 8. The method of claim 5 , wherein when P 1 and P 2 are both hydrogen atoms, then R is other than a hydrogen atom. 9. A method to treat airway inflammation comprising administration of a therapeutically acceptable amount of a composition of claim 4 . 10. The method of claim 9 , wherein P 1 and P 2 are each hydrogen atoms and R is a hydrogen atom. 11. The method of claim 9 , wherein said airway inflammation is asthma. 12. The method of claim 5 , wherein P 1 and P 2 are each hydrogen atoms and R is a hydrogen atom. 13. The method of claim 5 , wherein said airway inflammation is asthma.

Assignees

Inventors

Classifications

  • containing hydroxy or O-metal groups · CPC title

  • of unsaturated hydroxy carboxylic acids · CPC title

  • Antiasthmatics · CPC title

  • A61K31/202Primary

    having three or more double bonds, e.g. linolenic (eicosanoids, e.g. leukotrienes A61K31/557) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9364454B2 cover?
The invention describes novel isolated, purified, 10,17-dihydroxy-docosahexaenoic acids, esters, derivatives and their preparation.
Who is the assignee on this patent?
Serhan Charles N, Petasis Nicos A, Levy Bruce D, and 2 more
What technology area does this patent fall under?
Primary CPC classification A61K31/202. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).